Cardiovascular journalCurrentCardio coverage
JACC
What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.
Follow all of it, or only:You follow this. See your week →Explore J Am Coll Cardiol with filters →
- Recent
- 39 Briefs
- past 90 days
- Archive
- 676 Briefs
- research published Apr 2023 – Sep 2026
- Editorial
- –
- no Weekly issue published yet
- Impact Factor
- 22.3
- 2025 · Journal Citation Reports
Topics
- Coronary & ACS11617.2%
- Heart failure13019.2%
- Arrhythmias & EP548.0%
- Valvular & structural598.7%
- Hypertension324.7%
- Prevention & lipids8712.9%
- Cardiometabolic & kidney233.4%
- Aortic & peripheral182.7%
- Pulmonary vascular & VTE121.8%
- Congenital375.5%
- Acute care & resuscitation142.1%
- Cardio-oncology & other253.7%
Evidence types
- Randomised controlled trials10315.2%
- Secondary analyses11016.3%
- Meta-analyses527.7%
- Cohort studies25938.3%
- Case-control studies30.4%
- Cross-sectional studies263.8%
- Diagnostic & prognostic182.7%
- Mechanistic studies60.9%
- Guidelines & statements527.7%
- Other research477.0%
Shares are of the 676 Briefs CurrentCardio has covered from J Am Coll Cardiol, by primary topic and study type; a Brief without a primary topic is in no topic row.
Publication activity
- 2026166 Briefs
- 2025192 Briefs
- 2024181 Briefs
- 2023137 Briefs
Latest from JACC
J Am Coll Cardiol
Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease: 2026 ACC Scientific Statement
Guideline or statementPrevention & lipids
J Am Coll Cardiol
Intracoronary Imaging-Guided Percutaneous Coronary Intervention
Meta-analysisCoronary & ACS
J Am Coll Cardiol
Genetic Determinants of Early Heart Failure in Hypoplastic Left Heart Syndrome
Cohort studyCongenital
J Am Coll Cardiol
Genetically Mediated Differences in LDL Cholesterol and Risk of Venous Thromboembolism
Meta-analysisPulmonary vascular & VTE
J Am Coll Cardiol
Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities
Guideline or statementCardio-oncology & other
J Am Coll Cardiol
Cold Spells, Heat Waves, and Nonoptimal Air Temperature and Risk of Heart Failure Hospitalization in Sweden
Research articleHeart failure
J Am Coll Cardiol
Effect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)
Secondary analysisPrevention & lipids
J Am Coll Cardiol
Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis
Secondary analysisHeart failure
J Am Coll Cardiol
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy
Secondary analysisHeart failure
J Am Coll Cardiol
Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves
Randomised controlled trialValvular & structural
J Am Coll Cardiol
Stent Retriever Thrombectomy in Patients With Myocardial Infarction
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure
Meta-analysisHeart failure
J Am Coll Cardiol
Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis
Randomised controlled trialValvular & structural
J Am Coll Cardiol
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study
Secondary analysisPrevention & lipids
J Am Coll Cardiol
Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI
Secondary analysisCoronary & ACS
J Am Coll Cardiol
Addition of Computed Tomography–Derived Fractional Flow Reserve in the Diagnostic Pathway of Patients With Stable Coronary Artery Disease
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
Vericiguat for the Treatment of Coronary Vasospasm (ViVA)
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
A Coordinated Community- and Family-Based Intervention to Control Blood Pressure in Rural China
Randomised controlled trialHypertension
J Am Coll Cardiol
J Am Coll Cardiol
Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023
Research articleHeart failure
J Am Coll Cardiol
TEMPORARY REMOVAL: Cardiovascular Disease Mortality by County, Race and/or Ethnic Population, United States, 2000-2019
Research articleCardio-oncology & other
J Am Coll Cardiol
AI-ECG Detection of Structural Heart Disease in the Community Setting
Diagnostic or prognostic studyArrhythmias & EP
J Am Coll Cardiol
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
Guideline or statementArrhythmias & EP
J Am Coll Cardiol
Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI
Randomised controlled trialCoronary & ACS
J Am Coll Cardiol
Risk Reclassification Beyond BMI by Waist Circumference and Waist-to-Hip Ratio Across 9 Cardiovascular Outcomes
Cohort studyPrevention & lipids
J Am Coll Cardiol
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)
Randomised controlled trialHeart failure
J Am Coll Cardiol
Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease: 2026 ACC Scientific Statement
Guideline or statementPrevention & lipids
J Am Coll Cardiol
Impact of Left Ventricular Unloading on Hemodynamics and Stunning in Complex PCI
Secondary analysisCoronary & ACS
J Am Coll Cardiol
Acute Effects of Cannabis Inhalation on Cardiac Ectopy, Physical Activity, Sleep, and Glucose
Randomised controlled trialArrhythmias & EP
J Am Coll Cardiol
Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease
Cohort studyPrevention & lipids
J Am Coll Cardiol
Compound Exposure to Extreme Heat and Substantial Landscape Fire-Sourced Air Pollution on Cardiovascular Mortality
Research articleCardio-oncology & other
J Am Coll Cardiol
Health Status Outcomes 7 Years After Transcatheter or Surgical Aortic Valve Replacement in Low-Surgical Risk Patients With Aortic Stenosis
Secondary analysisValvular & structural
J Am Coll Cardiol
Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults
Cross-sectional studyPrevention & lipids
J Am Coll Cardiol
Timing, Translation, and Preparedness
Meta-analysisCardio-oncology & other
J Am Coll Cardiol
Long-Term Exposure to PM2.5 Constituents and Coronary Heart Disease Risk in China
Cohort studyCoronary & ACS
J Am Coll Cardiol
Myocardial Scar Assessment Using Artificial Intelligence-Powered Contrast-Free MRI
Diagnostic or prognostic studyCoronary & ACS
J Am Coll Cardiol
The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association’s PREVENT Calculator
Cohort studyPrevention & lipids
J Am Coll Cardiol
Natural History of Asymptomatic Phenotypically Mild HCM
Cohort studyHeart failure